MDI Therapeutics Investors, LLC
NOVI, MI · Founded 2018 · CIK 0001733018 · Biotech · Private
Novel small-molecule and biologic therapeutics for fibrosis and fibroproliferative diseases
mditherapeutics.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- —
- 1 Form D · Feb 2018
- 103 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1810 | MODERN MEADOW | — | $53M |
| 1811 | Sapience Therapeutics Inc. | — | $8.3M |
| 1812 | Marius Pharmaceuticals, LLC | — | $5.6M |
| 1813 | MDI Therapeutics Investors, LLC | — | — |
| 1814 | Rectify | — | — |
| 1815 | Phylo | — | — |
| 1816 | Pupil Bio, Inc. | — | $500K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Duane DayDirector
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.